Latest News & Features
Americas
A counsel for pharmaceutical company Eli Lilly has said that recent court decisions, including Ariosa v Sequenom, will create a bar to innovation. 16 October 2015
Americas
A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities. 16 October 2015
Americas
The US’s consul general in Rio de Janeiro has urged the US and Brazilian governments to work together to tackle the long delay in biotechnology-related patents being granted at Brazil’s intellectual property office. 15 October 2015
Americas
Pharmaceutical company Ranbaxy Laboratories, a subsidiary of Sun Pharma, has confirmed it has settled a patent lawsuit filed against Allergan. 15 October 2015
Americas
Law firm BakerHostetler has hired Allen Sokal as counsel in the firm’s intellectual property group in Washington, DC. 15 October 2015
Biotechnology
The Dutch lobby to amend Directive 98/44/EC on the legal protection of biotechnological inventions will severely damage the ability of the biotech sector to innovate—and for no tangible reason, says Annemiek Verkamman of HollandBIO. 15 October 2015
Asia
The High Court of Australia’s decision in Myriad has led some observers to hit the panic button and demand immediate legislative change, but only isolated naturally-occurring genes are affected and the ruling should be read in that light, says Grant Shoebridge of Shelston IP. 15 October 2015
Americas
Biotechnology company Enzo Biochem has settled a patent lawsuit after its rival Affymetrix agreed to pay $10 million to resolve the case. 14 October 2015
Americas
The double assessment of trademark applications for pharmaceutical products can cause problems for intellectual property owners, lawyers have claimed. 13 October 2015
Americas
Drug maker Mylan has been sued by pharmaceutical company Flamel Ireland for allegedly infringing a patent covering Coreg CR. 12 October 2015